BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 9469342)

  • 1. Telomerase activity in pleural effusions: diagnostic significance.
    Yang CT; Lee MH; Lan RS; Chen JK
    J Clin Oncol; 1998 Feb; 16(2):567-73. PubMed ID: 9469342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of the diagnostic value of telomerase activity with CEA level in benign and malignant pleural effusions].
    Yang Z; Xie C
    Zhonghua Jie He He Hu Xi Za Zhi; 2001 Apr; 24(4):201-3. PubMed ID: 11802962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limitations of detection of malignancy in pleural effusions using ELISA-based TRAP assay: comparison with cytological examination.
    Lee WY
    Cytopathology; 2005 Oct; 16(5):227-32. PubMed ID: 16181308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic implications of telomerase activity in pleural effusions.
    Dikmen G; Dikmen E; Kara M; Sahin E; Doğan P; Ozdemir N
    Eur Respir J; 2003 Sep; 22(3):422-6. PubMed ID: 14516130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic implications of telomerase activity in pleural effusions.
    Garcia-Pachon E; Padilla-Navas I
    Eur Respir J; 2004 Apr; 23(4):653-4. PubMed ID: 15083771
    [No Abstract]   [Full Text] [Related]  

  • 6. [Application of combined telomerase activity analysis and immunocytochemistry in cytopathologic diagnosis].
    Liu Y; Xu ML; Wang J; Wu BQ; Zhong HH; Fang WG
    Zhonghua Bing Li Xue Za Zhi; 2012 Mar; 41(3):181-5. PubMed ID: 22800482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different expression of FoxM1 in human benign and malignant pleural effusion.
    Tang Z; Li H; Zhu H; Bai C
    Med Oncol; 2015 Jan; 32(1):312. PubMed ID: 25491139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of the human telomerase RNA component by in situ hybridization in cells from body fluids.
    Nieh S; Chen SF; Fu E; Jan CI; Lee WH
    Acta Cytol; 2005; 49(1):31-7. PubMed ID: 15717752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble receptor-binding cancer antigen expressed on SiSo cells in pleural fluid: a potential diagnostic marker for malignant pleural effusion.
    Aoe K; Hiraki A; Maeda T; Murakami T; Yamazaki K; Sugi K; Takeyama H
    Chest; 2004 Oct; 126(4):1195-7. PubMed ID: 15486382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Idiopathic Pleural Effusions: Characteristics and Discrimination From Cytology-Negative Malignant Pleural Effusions.
    Park JE; Do YW; Lee DH; Lee SY; Lim JK; Choi SH; Seo HW; Yoo SS; Lee SY; Cha SI; Park JY; Lee J; Kim CH
    Am J Med Sci; 2020 Sep; 360(3):236-242. PubMed ID: 32423747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of exfoliative cell cytology in the diagnosis of exudative pleural effusions.
    Tetikkurt C; Yılmaz N; Tetikkurt S; Gundogdu Ş; Disci R
    Monaldi Arch Chest Dis; 2018 Sep; 88(3):944. PubMed ID: 30203633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of telomerase activity between malignant and tuberculous pleural effusions.
    Maneechotesuwan K; Lertworawiwat A; Tscheikuna J; Wamanuttajinda V
    J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S46-54. PubMed ID: 17718245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Adenosine deaminase activity in tuberculous and malignant pleural effusions].
    Safianowska A; Krenke R; Dmowska-Sobstyl B; Bogacka-Zatorska E; Domagała-Kulawik J; Chazan R
    Pneumonol Alergol Pol; 2006; 74(1):5-9. PubMed ID: 17175968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of malignant effusions: comparison of a telomerase assay and cytologic examination.
    Braunschweig R; Yan P; Guilleret I; Delacretaz F; Bosman FT; Mihaescu A; Benhattar J
    Diagn Cytopathol; 2001 Mar; 24(3):174-80. PubMed ID: 11241900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiating between malignant and idiopathic pleural effusions: the value of diagnostic procedures.
    Alemán C; Sanchez L; Alegre J; Ruiz E; Vázquez A; Soriano T; Sarrapio J; Teixidor J; Andreu J; Felip E; Armadans L; Fernández De Sevilla T
    QJM; 2007 Jun; 100(6):351-9. PubMed ID: 17525131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etiology and pleural fluid characteristics of large and massive effusions.
    Porcel JM; Vives M
    Chest; 2003 Sep; 124(3):978-83. PubMed ID: 12970026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pitfalls in TRAP assay in routine detection of malignancy in effusions.
    Braunschweig R; Guilleret I; Delacrétaz F; Bosman FT; Mihaescu A; Benhattar J
    Diagn Cytopathol; 2001 Oct; 25(4):225-30. PubMed ID: 11599105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic accuracy of human telomerase reverse transcriptase mRNA in malignant pleural effusions: A preliminary report for in situ hybridization detection.
    Shu J; Sun GY; Liu AP; Liu J
    Clin Chim Acta; 2007 Jun; 381(2):131-5. PubMed ID: 17399696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic usefulness of tumour marker levels in pleural effusions of malignant and benign origin.
    Kuralay F; Tokgöz Z; Cömlekci A
    Clin Chim Acta; 2000 Oct; 300(1-2):43-55. PubMed ID: 10958862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions.
    Porcel JM; Vives M; Esquerda A; Salud A; Pérez B; Rodríguez-Panadero F
    Chest; 2004 Dec; 126(6):1757-63. PubMed ID: 15596670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.